Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The FDA subsequently classified AOD-9604 within Category 2 of the bulk drug substance review process, and the compound was later withdrawn from that nomination in April 2026
Symptoms often begin to emerge when levels fall below 3.0 mmol/L, but this threshold is not absolute some individuals, particularly those with underlying heart disease, those taking digoxin, older adults, or those experiencing a rapid fall in potassium, may develop symptoms or ECG changes at levels between 3.0 and 3.5 mmol/L
It typically contains a blend of ingredients known as MIC: Methionine, Inositol, and Choline
The second incident was an injured ankle three years later
As of April 2026, BPC-157 is on the FDA's 503A Category 2 list
Related products More catalog records from the same research category
